Paras use Novozymes’ osteoporosis treatment technology Veltis
X
Waste Management Expo 2020 MAR 12&13 BIEC, Bengaluru, India

Paras to use Novozymes’ osteoporosis treatment technology Veltis

11:51 AM, 26th November 2015
Paras to use Novozymes’ osteoporosis treatment technology Veltis

OULU, FINLAND: Paras Biopharmaceuticals Finland Oy said that it has collaborated with Novozymes A/S to use the latter’s Veltis technology to develop a ‘once-a-week’ biobetter of Teriparatide, an improved version of an osteoporosis treatment.

Paras Biopharmaceuticals’ production technology platform for the biosimilar of Recombinant Teriparatide (Forteo Biosimilar) along with Veltis technology will offer new solutions offering the potential for enhanced patient adherence and improved therapeutic impact, the company said.

“Collective strengths of Paras Biopharmaceuticals’ and Novozymes’ technical expertise will bring solutions and treatment options for further convenience of osteoporosis patients,” said Dr Hans Soderlund, director, global strategic alliance, Paras Biopharmaceuticals.

“Novozymes’ Veltis technology and Paras Biopharmaceuticals’ Diabrid NobleCleav technology will create a superior osteoporosis medicine,” said Dr Ashesh Kumar, director, biologics and licensing, Paras Biopharmaceuticals.

© Worldofchemicals News

 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


DSM to boost Akulon XS capacity for flexible packaging films

HEERLEN, NETHERLANDS: Royal DSM said it is expanding production capacity for Akulon XS at its facility in Emmen, Netherlands. The capacity increase is ...

Read more
Tap water, salt in cooking may make food toxic: Study

BEIJING, CHINA: Cooking with chloraminated tap water and iodised table salt could put potentially harmful toxins in your food, a new study has warned. ...

Read more
Hikma sells certain parts of Ben Venue manufacturing site to Xellia

LONDON, UK: Hikma Pharmaceuticals Plc said it has agreed to sell its manufacturing facilities previously owned by Ohio-based Ben Venue Laboratories to ...

Read more
Sinarmas Cepsa acquires German sulfonation plant

MILAN, ITALY: Sinarmas Cepsa, Golden Agri-Resources (GAR) and Cepsa Quimica joint venture, said that its new subsidiary, Sinarmas Cepsa Deutschland, h ...

Read more
Borouge inaugurates innovation centre in Abu Dhabi

ABU DHABI, UAE: Borouge said it has officially inaugurated its innovation centre in Abu Dhabi, which plays a vital role in the company’s commitm ...

Read more
BASF names energy storage open innovation contest winners

LUDWIGSHAFEN, GERMANY: The winners of the BASF SE energy contest were announced at the “Creator Space Summit” in Ludwigshafen. From 122 ap ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X